EUVIMEDEUVIMED entdecken
Crossref

Inflammatory Pathways of Metabolic Disease: From Obesity to Systemic Dysfunction

Mercedes Carolina Freire Capelo, Laura Melissa Álvarez González, Manuel Maximiliano Paredes Ydiaquez, Eugenia González Castro, Irene Alejandra Apolo Fajardo, Isaac Muñoz Valle, Kristel Maylin Boya Baldeón, Luis Antonio Cortes Islas

IECCMEXICO · 12.11.2025 · 3 (1)

DOI: 10.64784/020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IECCMEXICO, online erschienen am 12.11.2025. Verfasst von Mercedes Carolina Freire Capelo und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic inflammation (metaflammation) is a key biological process linking obesity, insulin resistance, and chronic disease. This review integrates molecular and epidemiological evidence to explain how low-grade inflammation acts as both the cause and consequence of metabolic dysfunction. Adipose tissue functions as an immunometabolic organ, releasing cytokines and adipokines that disrupt insulin signaling and promote systemic complications. Major mediators—TNF-α, IL-6, CRP, leptin, resistin, and decreased adiponectin—constitute a proinflammatory network underlying metabolic syndrome, cardiovascular disease, and fatty liver. Using an integrative approach based on the DMAIC model (Define–Measure–Analyze–Improve–Control), this review synthesizes data from international and Latin American studies, emphasizing Mexico, Colombia, and Ecuador. Findings indicate that inflammation begins in adipose tissue and extends to the liver, skeletal muscle, cardiovascular system, and central nervous system, creating a self-perpetuating feedback loop. Regional data show high obesity and metabolic syndrome prevalence, driven by biological vulnerability and social factors such as diet, urbanization, and limited healthcare access. Effective management requires a multilevel strategy combining lifestyle modification, pharmacologic agents, targeted anti-inflammatory compounds, and public health interventions. Lifestyle change remains the cornerstone, supported by metabolic drugs and multidisciplinary programs. The evidence supports metaflammation as the unifying mechanism driving global metabolic disease. Recognizing it as a therapeutic and preventive target reframes clinical priorities, emphasizing the restoration of immunometabolic balance through integrative, context-specific action.

Zitieren

APA

Capelo, M. C. F., González, L. M. Á., Ydiaquez, M. M. P., Castro, E. G., Fajardo, I. A. A., Valle, I. M., Baldeón, K. M. B., & Islas, L. A. C. (2025). Inflammatory Pathways of Metabolic Disease: From Obesity to Systemic Dysfunction. IECCMEXICO, 3(1). https://doi.org/10.64784/020

Vancouver

Capelo MCF, González LMÁ, Ydiaquez MMP, Castro EG, Fajardo IAA, Valle IM, et al. Inflammatory Pathways of Metabolic Disease: From Obesity to Systemic Dysfunction. IECCMEXICO. 2025;3(1). doi:10.64784/020

BibTeX
@article{Capelo2025,
  author = {Capelo, Mercedes Carolina Freire and González, Laura Melissa Álvarez and Ydiaquez, Manuel Maximiliano Paredes and Castro, Eugenia González and Fajardo, Irene Alejandra Apolo and Valle, Isaac Muñoz and Baldeón, Kristel Maylin Boya and Islas, Luis Antonio Cortes},
  title = {Inflammatory Pathways of Metabolic Disease: From Obesity to Systemic Dysfunction},
  journal = {IECCMEXICO},
  year = {2025},
  volume = {3},
  number = {1},
  doi = {10.64784/020}
}
Kostenlos starten →